VIAL-IL13xTSLP

About VIAL Dermatology CRO

VIAL is a private, pre-revenue biotech company pioneering a tech-enabled approach to drug discovery and development. Its core strategy integrates computational target discovery, AI-driven molecule design (for antibodies, siRNA, and small molecules), and an automated clinical trial platform to increase speed and scalability. The company's initial pipeline features two Phase 1-ready assets in immunology and metabolic disease, positioning it to address significant unmet needs in large markets like atopic dermatitis, asthma, and obesity.

Therapeutic Areas